MAFM
AMED

Mid Atlantic Financial Management’s Amedisys AMED Stock Holding History

Mid Atlantic Financial Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$221K Sell
1,480
-310
-17% -$64.4K 0.01% 788
2021
Q2 		$438K Hold
1,790
– – 0.03% 518
2021
Q1 		$474K Hold
1,790
– – 0.03% 450
2020
Q4 		$525K Buy
1,790
+50
+3% +$12.8K 0.04% 379
2020
Q3 		$427K Hold
1,740
– – 0.04% 401
2020
Q2 		$345K Sell
1,740
-45
-3% -$8.39K 0.03% 442
2020
Q1 		$328K Buy
1,785
+550
+45% +$97.8K 0.04% 412
2019
Q4 		$206K Buy
+1,235
New +$184K 0.02% 637
2019
Q3 		– Sell
-1,922
Closed -$233K – 704
2019
Q2 		$233K Sell
1,922
-288
-13% -$34.2K 0.02% 598
2019
Q1 		$272K Buy
+2,210
New +$277K 0.03% 538

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Mid Atlantic Financial Management's AMED Position: Q3 2021 in Review

Mid Atlantic Financial Management reduced its Amedisys (AMED) stake by 17% in Q3 2021, selling an estimated $64.4K and leaving 1,480 shares worth $221K. The position accounts for 0.01% of the portfolio, ranked #788.

Mid Atlantic Financial Management first reported a position in AMED in Q1 2019 and has held it in 10 quarters since. The position peaked at $525K in Q4 2020. 352 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

  • Mid Atlantic Financial Management held 1,480 shares of Amedisys worth $221K as of Q3 2021.
  • Mid Atlantic Financial Management sold 310 Amedisys shares in Q3 2021, an estimated $64.4K.
  • Amedisys made up 0.01% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #788 holding.
  • Mid Atlantic Financial Management first reported a position in Amedisys in Q1 2019 and has held it in 10 quarters since.
  • Mid Atlantic Financial Management's Amedisys position peaked at $525K in Q4 2020.
  • 352 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.